PRB-6014

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NamePRB-6014
Drug Alias NamePRB-6014
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLipid metabolism modulators
TargetsUpdating
Therapy Area/IndicationsLipid Metabolism Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNorway
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPronova BioPharma ASA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPronova BioPharma ASA
Active IndicationsN/A
Inactive IndicationsLipid Metabolism Disorders

Other Information

ATC CodeN/A
Related LinksN/A